Study at a glance
Can a blood test show that vitamin D has made the immune system younger?
No single test can establish that. Cell proportions, gene activity and inflammation markers describe different features. They do not by themselves show better protection against illness.
Does a different mix of immune cells mean better immunity?
Not automatically. It may reflect a different balance of cell types. An association with vitamin D does not show that vitamin D caused the change or that the change improved function.
What does an improved immune response in the skin show?
It shows a change in that local test. In the older-adult study discussed here, there was no comparison group assigned by chance. This limited conclusions about vitamin D’s effect and did not establish protection throughout the body.
Read the full article below ↓An immune-ageing measurement is useful only when its meaning is clear. A cell count, a gene-expression result, a skin response and an inflammatory blood test describe different things. None alone tells us that an older person’s whole immune system has become younger or more effective. This guide explains how to read those measurements in vitamin D research.
Cell proportions describe a mixture
A blood sample contains several kinds of immune cells. Researchers may report the proportion classified as naïve, meaning cells without the same antigen experience as more differentiated cells, or as effector cells that carry out immune responses. A different proportion is a description of the sample; it is not automatically a better result.
Hwang and colleagues found an association between higher vitamin D and a different mixture within CD8 T cells, a group of immune cells, in older women. Because the study observed people at one time point, it could not establish that vitamin D caused the pattern. It also did not establish that the pattern improved protection. The broader population context is Vitamin D in Older Adults.
A cellular marker is not a direct age reading
Senescence describes a cellular state in which normal division is restricted and other cell activities can change. Senescence-related assays are laboratory tests for selected properties associated with that state. Rastgoo and colleagues measured enzyme staining and gene expression, which measures how actively particular genetic instructions are being used, in a mixed population of blood immune cells. Some results changed under higher vitamin D regimens while others did not. The experiment did not demonstrate that aged cells were removed or that the participants became resistant to infection.
Different assays can disagree without one necessarily being meaningless. They may reflect different processes, cell mixtures or measurement limitations. The important question is whether the study shows that the measured change predicts or causes a meaningful improvement in function. That connection should be demonstrated, not supplied by the word ageing.
A local response is closer to function, but still local
A skin response to a previously encountered antigen asks whether an immune reaction can be expressed in that tissue. An antigen is something the immune system recognises. Chambers and colleagues used this approach in older adults during vitamin D replacement. The clinical response improved overall, but the absence of a randomised control limited causal interpretation.
The result is relevant to Vitamin D and Immune Memory, which concerns responses after earlier immune encounters. It does not establish improved protection throughout the body. The local clinical score and the gene-expression results are also separate outcomes; an improvement in one does not mean every molecular comparison improved.
Inflammation tests need a time point and a consequence
Vitamin D and Chronic Inflammation describes persistent inflammation. A circulating marker can help characterise inflammatory activity, but its change needs to be interpreted alongside other markers, the testing interval and clinical outcomes. VITAL’s inflammation analysis found a difference in C-reactive protein at two years that was not sustained at four years. It did not establish that the temporary difference improved immune competence.
The practical reading sequence is to identify what was measured, whether treatment was randomly assigned, which comparison changed, and whether a functional outcome was demonstrated. That keeps a useful biological clue from becoming a claim of immune rejuvenation. The full evidence comparison is in Vitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review.
Sources
Related reading
Vitamin D as a Shield against Aging
To this aim, the main biomolecular paths underlying immunosenescence and inflammaging are identified as biotargets of vitamin D.
Original paper ↗Read more →Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Original paper ↗Read more →Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Original paper ↗Read more →Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review
Review VITAL, DO-HEALTH and TILDA findings on vitamin D, inflammatory markers, biological ageing and metabolic risk, with causal limits explained.
Read more →Vitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review
Evidence on vitamin D, immune-cell ageing, recall responses and inflammageing.
Read more →Vitamin D, Immune Ageing and the Gap Between Markers and Function: Study Summary
What studies in older adults found about vitamin D, immune cells and inflammation, explained simply with the main limits and null results.
Read more →Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo
Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases.
Original paper ↗Read more →Vitamin D Supplementation and Low-Grade Inflammation in Deficient Adults: Study Summary
Summary of a vitamin D trial in deficient adults: higher blood levels, no clear inflammatory improvement, and key limits of the 16-week findings.
Read more →Effects of fish and krill oil on gene expression in peripheral blood mononuclear cells and circulating markers of inflammation: a randomised controlled trial
In an 8-week trial, healthy men and women aged 18 to 70 years with fasting TAG of 1·3 to 4·0 mmol/l were randomised to receive krill oil capsules (n 12), HOSO capsules (n 12) or lean and fatty fish (n 12).
Original paper ↗Read more →3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice
Herein, 40 male low‐density lipoprotein receptor knockout (LDLR −/−) mice were randomized into five groups: normal diet (ND), high‐cholesterol diet (HCD), and three 3′‐SL groups (low dose SLL, medium dose SLM, high dose SLH).
Original paper ↗Read more →Associations of systemic immune‐inflammation index with high risk for prostate cancer in middle‐aged and older US males: A population‐based study
The principal objective of this investigation was to elucidate the association between SII and the risk for PCa in middle‐aged and elderly males.
Original paper ↗Read more →Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study
This study aimed to investigate the association between platelet indices and the derived systemic immune inflammation index (SII) with fracture risk in postmenopausal women.
Original paper ↗Read more →High systemic immune‐inflammation index is relevant to osteoporosis among middle‐aged and older people: A cross‐sectional study
As one of novel inflammatory indexes proposed in recent years, systemic immune‐inflammation index (SII) can comprehensively reflect the inflammatory and immune state of the body.
Original paper ↗Read more →Immune risk phenotype and long-term mortality after community-acquired pneumonia in older adults: clinical and immune determinants
Community-acquired pneumonia (CAP) has been associated with poor long-term outcomes in older adults.
Original paper ↗Read more →Parathyroidectomy Positively Modulates Systemic Inflammation and Nutritional Status: Immune-Inflammation Index and Prognostic Nutritional Index in Primary Hyperparathyroidism
Background/Objectives: Primary hyperparathyroidism (PHPT) has been associated with systemic inflammation and metabolic disturbances.
Original paper ↗Read more →The Role of Vitamin D3 in Periodontal Health: Implications for Bone Metabolism, Immune Modulation and Inflammation Control
Vitamin D3 is a fat-soluble steroid essential for bone metabolism, immune modulation, and inflammation control, all critical for periodontal health.
Original paper ↗Read more →Emma Chambers shares a finding about inflammation in ageing skin cells
The researcher used a publication announcement to explain a change observed in skin fibroblasts.
Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study
Examine vitamin D research on endothelial inflammatory signalling and immune-cell adhesion, with clear limits on what it establishes about cardiovascular risk.
Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Study Summary
A concise guide to endothelial inflammation and vitamin D: what cell experiments measure, where their findings differ, and why clinical benefit remains uncertain.
Read more →Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Study Summary
A concise summary of vitamin D findings on long-term inflammation, ageing markers and metabolic risk, separating trials from observational associations.
Read more →Vitamin D and Chronic Inflammation
Explains how vitamin D relates to chronic inflammation, including cytokine balance, immune regulation, metabolic links, and long-term inflammatory signalling, without making treatment claims.
Read more →Original sources
Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging
Published in Advances in aging research. 2(2):72-80. DOI: 10.4236/aar (2013).
Publication details
Hwang et al. (2013). Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging. Advances in aging research. 2(2):72-80. DOI: 10.4236/aar.2013.22010.
Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu (2025).
Publication details
Rastgoo et al. (2025). Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu.2025.1570441.
Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu (2025).
Publication details
Rastgoo et al. (2025). Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu.2025.1627178.
Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Publication details
Chambers et al. (2021). Vitamin D3 replacement enhances antigen-specific immunity in older adults. Immunotherapy Advances. 1(1):ltaa008. DOI: 10.1093/immadv/ltaa008.
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Publication details
Dong et al. (2022). Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 14(24):5307. DOI: 10.3390/nu14245307.